Kagawa, Tomoko
Kurahashi, Kiyoyasu https://orcid.org/0000-0003-2484-3769
Seki, Tomotsugu
Kawasaki, Yohei
Nahara, Isao
Takeda, Chikashi
Yonekura, Hiroshi
Tanaka, Shiro
Kawakami, Koji
Funding for this research was provided by:
Japan Agency for Medical Research and Development (19lk0201061h0004)
Article History
Received: 13 April 2023
Accepted: 14 November 2023
First Online: 15 December 2023
Declarations
:
: Koji Kawakami received advisory fees from Shin Nippon Biomedical Laboratories, Ltd, Japan; JMDC Inc., Japan; LEBER Inc., and CICS, Japan; research funds from Eisai, Kyowa Kirin, and Real World Data, Co, Ltd, Japan; and held stock of Real World Data, Co, Ltd, Japan. Kiyoyasu Kurahashi receives advisory fees from Masimo Corporation Japan, Japan, and research funds from the International University of Health and Welfare, Japan, Maruishi Pharmaceutical Co. Ltd., MSD K.K., Japan, and Japan Blood Products Organization, Japan. Other authors have no direct or indirect conflicts of interest.